Related Experiment Videos
Stable lines of genetically modified dendritic cells from mouse embryonic stem cells
Paul J Fairchild1, Kathleen F Nolan, Siân Cartland
1University of Oxford, Sir William Dunn School of Pathology, South Parks Road, Oxford, United Kingdom. Paul.Fairchild@path.ox.ac.uk
Transplantation
|August 19, 2003
Summary
Researchers developed a method to genetically modify dendritic cells (DCs) using embryonic stem cells. This breakthrough allows for unlimited production of mutant DCs, advancing immunotherapy research and understanding of immune responses.
Area of Science:
- Immunology
- Cell Biology
- Stem Cell Research
Background:
- Dendritic cells (DCs) are crucial antigen-presenting cells for T cell activation.
- Understanding DC molecular mechanisms is vital for immune intervention but hindered by genetic modification resistance.
Purpose of the Study:
- To overcome limitations in genetically modifying terminally differentiated DCs.
- To establish a system for producing large quantities of genetically defined DCs.
Main Methods:
- Directed differentiation of cloned embryonic stem cells (ESCs) into DCs.
- Stable transfection of ESCs with a reporter gene (enhanced green fluorescent protein).
- Analysis of DC phenotype, immunogenicity, and maturation post-differentiation.
Main Results:
- Successful derivation of long-term cultures of untransformed DCs with a defined mutant phenotype.
- Reporter gene expression in ESCs did not affect DC differentiation or function.
- Demonstrated uniform expression of the reporter gene in differentiated DCs.
Conclusions:
- Enables unlimited production of mutant DCs from genetically modified ESCs.
- Facilitates systematic elucidation of gene function in DCs.
- Supports rational design of DCs for advanced immunotherapy strategies.